o Population screening of vitamin D blood levels is not recommended. o Lifestyle advice and use of over the counter vitamin D preparations are recommended for prevention. Patient information resources are included in this guideline. o The government Healthy Start Scheme offers free vitamin supplements (containing vitamin D) to eligible patients. They can also be purchased cheaply by those not eligible for free supplies. o Prescriptions of vitamin D preparations should be reserved for treatment of patients with symptoms AND low vitamin D levels and those patients who have an indication for supplementation but are unable to access non-prescription vitamin D supplementation such as the elderly and infirm.
Pharmacy keep the following strengths of Vitamin D (prescribed as colecalciferol):
50,000 units, 20,000 units and 10,000 units for high dose treatment SUMMARY: Diagnosis and management of Vitamin D deficiency in primary care Population screening by measuring Vitamin D levels is unnecessary, even in high risk populations.
Symptoms of rickets or osteomalacia?
(See table 1 This guideline has been revised for 2013 following the publication of the National Osteoporosis Society "Vitamin D and Bone Health" document and new developments in the commercial field of vitamin D supplements. The document provides information on vitamin D, diagnosis and management of deficiency and advice for patients with insufficiency 1: Vitamin D physiology:
What is Vitamin D?
Vitamin D is a group of fat soluble vitamins that is essential bone formation in all age groups. The 2 main forms are D2 (ergocalciferol), predominantly from plants and D3 (colecalciferol), mainly from animal sources. Both have similar actions. Vitamin D is activated in the liver to 25-hydroxycolecalciferol and then in the kidney to 1,25dihydroxycolecalciferol (active vitamin D). The most well established action of vitamin D is to promote calcium absorption by the GI tract. 90% of our daily vitamin requirement is obtained by the action of UVB sunlight on the skin (only during April to September in the United Kingdom) 10% is obtained through diet such as oily fish (sardines, salmon), liver, egg yolks, fortified margarine and fortified breakfast cereals)
Does Vitamin D have other functions?
Research has identified epidemiological links between vitamin D levels and various disease states. It remains unclear whether vitamin D could offer pharmacological benefit for any of these conditions. At the present time the indications for vitamin D treatment relate to maintenance of calcium homeostasis and bone health via the primary mode of action to aid absorption of calcium at the gut.
2: Prevention of Vitamin D deficiency:
All UK Health Departments recently recommended (CMO letter 2012) that:
All pregnant and breastfeeding women should take a daily supplement containing 400 international units (iu) (10micrograms (μg)) of vitamin D, to fulfil mother"s requirements for vitamin D and to build adequate foetal stores All infants and young children aged 6 months to 5 years should take a daily supplement containing 280-340iu (7-8.5μg) vitamin D in the form of vitamin drops. However, those infants who are fed infant formula will not need vitamin drops until they are receiving less than 500ml of infant formula a day. Breastfed infants may need to receive drops containing vitamin D from one month of age if their mother has not taken vitamin D supplements throughout pregnancy. People aged 65 years and over and people who are not exposed to much sun should also take a daily supplement containing 400iu (10μg) of vitamin D.
Most of these patients should be offered lifestyle advice as detailed in section 5 (p6) and advised to purchase supplementation over the counter in the first instance (eligible patients can obtain free supplements through the Healthy Start scheme). More information on available products for supplementation and the Healthy Start scheme can be found in appendix 2 (p8). Patients who are unable to access over the counter supplements and are unable to modify lifestyle behaviour adequately should be prescribed the relevant supplement. Relevant groups include patients in Residential and Nursing homes and those unable to afford supplements.
3: Diagnosis:
Vitamin D deficiency is best assessed by measurement of serum 25-OH vitamin D. Measurement of other vitamin D metabolites or sub-fractions adds nothing further and is not recommended.
Population screening is NOT recommended. Vitamin D deficiency should be suspected in patients presenting with clinical features as detailed in table 1 below and the general principle is to test only those individuals who have symptoms or features suggestive of vitamin D deficiency or osteomalacia. For the purposes of this document we define "treatment" to be high dose therapy to reverse vitamin D deficiency. This is different from lower doses used as long term daily "supplementation" or as "maintenance" following high dose treatment.
Clinical features of Vitamin D deficiency (
Symptomatic patients need high dose colecalciferol treatment to reverse deficiency and eradicate symptoms. Asymptomatic patients can usually be commenced on lower doses of colecalciferol (see Maintenance Therapy in section 3 of Table 3 ) and deficiency will gradually be resolved.
When indicated a single course of high dose therapy should be followed by lifestyle advice and maintenance with lower dose supplementation.
Available evidence suggests that oral colecalciferol offers greater improvements in serum 25-OH Vitamin D compared with oral ergocalciferol or intramuscular preparations at equivalent doses. As such, oral colecalciferol is the first line treatment option.
Alfacalcidol and calcitriol are completely inappropriate for treatment of vitamin D deficiency outside of CKD 4-5, due to high risk of toxicity.
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Long term monitoring
No routine monitoring or rechecking of serum 25OHD levels is needed whilst on maintenance therapy. Recheck biochemistry if symptoms return or malabsortion/ poor compliance suspected. NB: *Loading regimens for treatment of deficiency up to a total of approximately 300,000 IU given either as weekly or daily split doses. The exact regimen will depend on the local availability of vitamin D.
NB: **The same effect may be achieved by multiplying the dose by seven and giving it weekly if compliance is a concern NB: Where poor compliance is suspected give supervised stat oral doses (100,000 iu colecalciferol for adults) at weekly intervals NB: Liquid "specials" of vitamin D (unlicensed) should NOT be routinely prescribed. Cost effective alternatives are available.
NB: Most vitamin D preparations contain gelatin. Hux D3 & Pro D3 are vegetarian and Halal products.
NB:
In patients where Fultium D3® is intolerable, or an alternative is required for maintenance, OTC preparations are advised (see Appendix 2).
5: Management of Vitamin D insufficiency: i.e.: Vitamin D level 30-50nmol/l AND risk factors for Vitamin D deficiency
Patients should be offered lifestyle advice and advised to purchase supplements over the counter (OTC) at doses outlined above for maintenance therapy (see Appendix 2). Healthy start vitamins are available for children <5years. Example patient information leaflets can be found in Appendix 1.
Use of colecalciferol supplements is specifically recommended for patients with 25-OH Vitamin D 30-50 nmol/l and one of the following additional factors; fragility fracture, osteoporosis or high fracture risk including patients on antiresorptive mediactions increased risk of future deficiency due to e.g. reduced exposure to sunlight, cultural dress code, dark skin (see Special Circumstances 4. Asian populations) raised PTH regular prescription for antiepileptic drugs or glucocorticoids malabsorption
Lifestyle advice for Vitamin D insufficiency (and deficiency) Sun exposure: Sun exposure is the main source of vitamin D and should be exploited! However, this should be balanced with the risks of excessive exposure. Time required in the sun to make sufficient vitamin D is generally short and less than the time needed for skin to burn. This should be adjusted on an individual basis and safe practices adopted. Little and often is best. The following advice was given in the New England Journal of Medicine (2007):
"Exposure of arms and legs for 5 to 30 minutes (depending on time of day, season, latitude, and skin pigmentation) between the hours of 10 a.m. and 3 p.m. twice a week is often adequate"
Note: Use of creams containing sun protection factors reduces vitamin D synthesis by >95%. It is difficult to obtain enough vitamin D from usual diet alone. The average daily intake from a normal diet is just 80-160iu/day (2-4µg). Where supplementation is indicated, the following doses are recommended ( 
c. Elderly patients
The majority of elderly patients are ambulant and community dwelling. Many will still be at risk of vitamin D deficiency but the principles of management are not different to that presented in the rest of this document. Dual supplementation with calcium and low dose vitamin D (as in numerous commercially available preparations) is more likely to be appropriate in the elderly and infirm where sun exposure is likely to be poor and gastrointestinal calcium absorption reduced.
Occasionally lone vitamin D supplementation may be needed (eg concurrent primary hyperparathyroidism) and in these cases, a prescription vitamin D supplement such as Fultium D3 should be given.
Meta-analysis suggests that Vitamin D supplementation may prevent falls, although this is controversial. Vitamin D supplementation (with or without calcium) will invariably be appropriate in recurrent fallers. In some cases high dose supplementation will be recommended in this context on a case by case basis by the Falls Clinic team (Vitamin D deficiency has been shown by local Audit to be almost ubiquitous in the Falls clinic population so testing of deficiency prior to treatment will not always be needed). Older people with falls should be assessed for their falls risk factors and referred as per local guidelines.
d. Asian populations
A combination of skin type and cultural factors which reduce sun exposure and limit dietary and supplement choices mean that Asian patients are at particular risk of Vitamin D deficiency and have particular barriers to effective treatment.
In fact vitamin D insufficiency is almost ubiquitous in this group and virtually all patients will be appropriate for supplementation. It is known that take up of "Over the Counter" options is low in this group.
e. Parenteral Osteoporosis treatments
Parenteral treatments for osteoporosis require adequate vitamin D levels in order to be safe and effective. The osteoporosis team will be involved with the care of these patients and will optimise vitamin D prior to initiation of treatment. It is vital that vitamin D levels are adequate prior to each injection to minimise the risk of severe hypocalcaemia. Vitamin D levels should be checked in patients who are not on regular supplements or in those whose compliance is suspected to be poor. The aim is to ensure 25-OH Vitamin D levels are greater than 50 nmol/l prior to treatment.
7: Referral:
The following patients should be referred to secondary care for further investigation: Children under 1 year Children with biochemical rickets or raised PTH Renal disease (CKD 4&5) Atypical biochemistry-including hypercalcaemia Failure to respond to treatment after 3 months Short stature / skeletal deformity Focal bone pain Unexplained severe deficiency Unexplained weight loss
